Gera Goverse, Nataliia Beztsinna, Benjamin Visser, Tomas Veenendaal, Marjan van de Merbel, Emma Spanjaard, Ashgard Weterings, Kuan Yan, Leo Price, Lidia Daszkiewicz
Crown Bioscience Netherlands, Leiden, The Netherlands
Myeloid cells play an important role in anti-tumor immune responses, having both cancer-promoting and cancer-restraining actions. Unleashing the full potential of cancer immunotherapies requires an understanding of the cellular mechanisms that govern these opposite actions. Therefore, to further increase the biological relevance of our assay, we incorporated the myeloid cell compartment into the co-cultures of tumor cells and T cells to measure the effects of immune-modulators.
This poster details our in-house developed image analysis software and machine learning, a set of morphological features was identified that reproducibly allowed discrimination between undifferentiated monocytes, M1 and M2 macrophages and dendritic cells. In addition, these phenotypic profiles of the myeloid cells could be analyzed in the presence of the tumor supernatants or in co-cultures with tumor cells. This assay thereby allows a better understanding of the suppressive tumor microenvironment including multiple cell types and is well suited to test different cancer immunotherapies.
Your privacy is important to us.
We'll never share your information.
© 2024 Crown Bioscience. All Rights Reserved.
© 2024 Crown Bioscience. All Rights Reserved. Privacy Policy
2023-02-19
2021-10-27
landing_page
PDX/Databases